TenNor Announces Positive Topline Results from Rifasutenizol Phase III Trial for H. pylori Infection
Hand-out
Press Releases

TenNor Announces Positive Topline Results from Rifasutenizol Phase III Trial for H. pylori Infection

SUZHOU, China, Nov 18, 2024 /PRNewswire/ -- TenNor Therapeutics, a clinical-stage company dedicated to developing novel therapies to address unmet needs in infectious diseases, announced today the successful completion of

avatar profile Olean Times Herald

Olean Times Herald


Local & Social